Effect of metal ions and calcium on purified PON1 and PON3 from rat liver

Chemico-Biological Interactions

Volumn 167, Issue 1, 2007, Pages 63-70

  Pla, A ^a   Rodrigo, L ^a   Hernandez A F ^a   Gil, F ^a   Lopez, O ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Calcium; Mercurials; Metal ions; Paraoxonase; PON1; PON3; Rat liver

Indexed keywords

4 HYDROXYMERCURYBENZOATE; ARYLDIALKYLPHOSPHATASE; ARYLDIALKYLPHOSPHATASE 1; CALCIUM; COBALT; COPPER ION; EDETIC ACID; MANGANESE; MERCURY; MERCURY DERIVATIVE; METAL ION; PARAOXONASE 3; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DETOXIFICATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PURIFICATION; NONHUMAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RAT; TIME;

RATTUS;

EID: 33947177549     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2007.01.006     Document Type: Article

References (33)

1. Primo-Parmo S.L., Sorenson R.S., Teiber J., and La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics 33 (1996) 498-507
2. La Du B.N., Aviram N., Billecke S., Navab M., Primo-Parmo S., Sorenson R.C., and Standiford T.J. On the physiological role(s) of the paraoxonases. Chem.-Biol. Interact. 119-120 (1999) 379-388
3. Mackness M.I., Hallam S.D., and Walker C.H. A-esterase activity in the lipoprotein fraction of sheep and human serum. Biochem. Soc. Trans. 13 (1985) 135-136
4. Mackness M.I., Arrol S., Abbot C., and Durrington P.N. Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase. Atherosclerosis 104 (1993) 129-135
5. Draganov D.I., Stetson P.L., Watson C.E., Billecke S.S., and La Du B.N. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J. Biol. Chem. 275 (2000) 33435-33442
6. Reddy S.T., Wadleigh D.J., Grijalva V., Ng C., Hama S., Gangopadhyay A., Shih D.M., Lusis A.J., Navab M., and Fogelman A.M. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 542-547
7. Harel M., Aharoni A., Gaidukov L., Brumshtein B., Khersonski O., Meged R., Dvir H., Ravelli R.B.G., McCarthy A., Toker L., Silman I., Sussman J.L., and Tawfik D.S. Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat. Struct. Mol. Biol. 11 (2004) 412-419
8. Draganov D.I., Teiber J.F., Speelman A., Osawa Y., Sunahara R., and La Du B.N. Human paraoxonases (PON1, PON2 and PON3) are lactonases with overlapping and distinct substrate specificities. J. Lipid Res. 46 (2005) 1239-1247
9. Draganov D.I., and La Du B.N. Pharmacogenetics of paraoxonases: a brief review. Naunyn-Smiedeberg's Arch. Pharmacol. 369 (2004) 78-88
10. Rodrigo L., Hernández A.F., Lopez-Caballero J.J., Gil F., and Pla A. Immuno-histochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue. Implications for its physiological role. Chem.-Biol. Interact. 137 (2001) 123-137
11. Shamir R., Hartman C., Karry R., Pavlotzky E., Eliakim R., Lachter J., Suissa A., and Aviram M. Paraoxonases (PONs) 1, 2 and 3 are expressed in human and mouse gastrointestinal tract in Caco-2 cell line: selective secretion of PON1 and PON2. Free Rad. Biol. Med. 39 (2005) 336-344
12. Costa L.G., Vitalone A., Cole T.B., and Furlong C.E. Modulation of paraoxonase (PON1) activity. Biochem. Pharmacol. 69 (2005) 541-550
13. Gil F., Pla A., Golzalvo M.C., Hernández A.F., and Villanueva E. Rat liver paraoxonase: subcellular distribution and characterization. Chem.-Biol. Interact. 87 (1993) 149-154
14. Gil F., Gonzalvo M.C., Hernandez A.F., Villanueva E., and Pla A. Differences in the kinetic properties, effect of calcium and sensitivity to inhibitors of paraoxon hydrolase activity in rat plasma and microsomal fraction from rat liver. Biochem. Pharmacol. 48 (1994) 1559-1568
15. Gonzalvo M.C., Gil F., Hernández A.F., Villanueva E., and Pla A. Inhibition of paraoxonase activity in human liver microsomes by exposure to EDTA, metals and mercurials. Chem.-Biol. Interact. 105 (1997) 169-179
16. Gonzalvo M.C., Gil F., Hernández A.F., Rodrigo L., Villanueva E., and Pla A. Human liver paraoxonase (PON1): subcellular distribution and characterization. J. Biochem. Mol. Toxicol. 12 (1998) 61-69
17. Rodrigo L., Gil F., Hernández A.F., Marina A., Vazquez J., and Pla A. Purification and characterization of paraoxon hydrolase from rat liver. Biochem. J. 321 (1997) 595-601
18. Rodrigo L., Gil F., Hernández A.F., López O., and Pla A. Identification of paraoxonase 3 in rat liver microsomes: purification and biochemical properties. Biochem. J. 376 (2003) 261-268
19. Gil F., Pla A., Golzalvo M.C., Hernández A.F., and Villanueva E. Partial purification of paraoxonase from rat liver. Chem.-Biol. Interact. 87 (1993) 69-75
20. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
21. Wang C.S., and Smith R.L. Lowry determination of protein in the presence of Triton X-100. Anal. Biochem. 63 (1951) 414-417
22. Dixon M. The determination of enzyme inhibitor constants. Biochem. J. 55 (1953) 170-171
23. Cornish-Bowden A. A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem. J. 137 (1974) 143-144
24. Segel I.H. Enzyme Kinetics. Behavior and analysis of rapid equilibrium and steady-state enzyme systems (1975), John Wiley & Sons, New York
25. Cortés A., Cascante M., Cárdenas M.L., and Cornish-Bowden A. Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data. Biochem. J. 357 (2001) 263-268
26. Cornish-Bowden A. Fundamentals of Enzyme Kinetics (2004), Portland Press, London
27. Aldridge W.N. Serum esterases 2. An enzyme hydrolysing diethyl p-nitrophenyl phosphate (E600) and its identity with the A-esterase of mammalian sera. Biochem. J. 53 (1953) 117-124
28. Erdös E.G., Debay C.R., and Westerman M.P. Arylesterases in blood: effect of calcium and inhibitors. Biochem. Pharmacol. 5 (1960) 173-186
29. Kojima K., and ÓBrien R.D. Paraoxon hydrolyzing enzymes in rat liver. J. Agric. Food Chem. 16 (1968) pp. 574-514
30. Shishido T., and Fukami J.I. Enzymatic hydrolysis of diazoxon by rat tissue homogenates. Pestic. Biochem. Physiol. 2 (1972) 39-50
31. Rodrigo L., Gil F., Hernandez A.F., and Pla A. Identification of two rat liver proteins with paraoxonase activity: biochemical evidence for the identity of paraoxonase and arylesterase. Chem.-Biol. Interact. 119-120 (1999) 263-275
32. Josse D., Lockridge O., Xie W., Bartels C.M., Schopfer L.M., and Masson P. The active site of human paraoxonase (PON1). J. Appl. Toxicol. 21 (2001) S7-S11
33. Kuo C., and La Du B.N. Calcium binding by human and rabbit serum paraoxonases. Drug. Metab. Dispos. 26 (1998) 653-660